Blog

CQ fluency Celebrates Women’s History Month: Meet Six Boundary-Breaking Women in Healthcare

As Women’s History month and the one-year anniversary of COVID-19 roll into one, we take this time to celebrate and call attention to the fearless females who have shaped the future of healthcare. Here are some key figures in the history healthcare, alongside some of the trailblazers who are leading the charge against COVID-19. Katalin […]

MDR Date of Application is STILL May 26, 2021 – Are You Prepared for Language Compliance?

After entering into force on May 25, 2017, the European Union (EU) Medical Device Regulation (MDR) EU 2017/745 will be applied to all Member States from May 26, 2021, after a one-year extension due to the ongoing pandemic. In a previous blog post, we discussed the key aspects of the regulation, namely the stricter regulatory […]

Harnessing the Power of Fact-Based COVID-19 Vaccine Information

“You’ve earned the right to ask the questions you have around these vaccines and this vaccine development process. Trust-especially when it has been stripped from people- has to be rebuilt in a brick-by-brick fashion.” – Dr. Kizzmekia Corbett, Coronavirus Vaccines & Immunopathogenesis Team at the National Institutes of Health (NIH) There is a light at […]

Tackling Covid-19 Vaccine Hesitancy in Limited English Proficient Communities: Lessons From the Flu Shot.

2020 was an unprecedented year of innovation in healthcare. The Covid-19 pandemic led to numerous scientific advances in diagnostics, treatments and vaccines to combat the SARS-CoV2 coronavirus. But developing vaccines is just one part of the effort to end the pandemic, encouraging people to take them is another challenge. Previous widespread vaccination campaigns, such as […]

Why Linguistic Validation is Crucial To Ensuring eCOA is Culturally and Conceptually Equivalent

Over the last 20 years, the worldwide number of clinical trials has increased exponentially. Clinical trials also become more complex, with the adoption of multi-center, international interventions becoming the norm. This means that the pharmaceutical industry is confronted with the exponential growth in costs associated with running such clinical trials, with each molecule requiring approximately […]

Get Ahead of AEP 2022

After overcoming the challenges posed by COVID-19, you’re in a great position to determine which strategies will help you streamline next year’s AEP season. As the impact of the pandemic continues into 2021, broker meetings and seminars will go virtual once again. That means you’ll need to determine how to digitally connect with all beneficiaries—including […]

Cultural Relevance in Medical Adherence: Pre, During and Post Pandemic

In the US, medical non-adherence accounts for 30-50% percent of chronic disease treatment failures and close to 125,000 preventable deaths each year, representing losses of $637 billion for the pharmaceutical industry. The COVID-19 pandemic has created additional strain as healthcare utilization dropped significantly .  82% of healthcare providers surveyed indicated a significant decline in appointments […]

How Cultural Competence Reduces Costs for Medicare and Medicaid Recipients

As Medicare and Medicaid increasingly move away from fee-for-service payments, healthcare systems and providers must adapt to alternative models that include financial risk. However, those costs aren’t spread out evenly among the patient population. Just 5% of Medicaid recipients make up 54% of the total Medicaid expenditure, for example. While this subset of beneficiaries, known […]

AEP Toolkit: Maximizing Reach to Diverse Medicare Members in the context of COVID-19

The 2021 Medicare Annual Election Period (AEP) poses several unique challenges for health insurance providers. Due to COVID-19, seniors are interacting with marketing in different ways, CMS approval times are uncertain, and social distancing is impacting methods of enrollment. The need for translated documents and language support add another layer of complexity when you want […]

Combating the Limitations of Telehealth for Non-English Speakers

During the COVID-19 pandemic, consumer adoption of telehealth has skyrocketed, from 11% of U.S. consumers using telehealth in 2019 to 46% of consumers now using telehealth to replace canceled healthcare visits, according to consulting firm McKinsey & Company’s COVID-19 consumer survey conducted in April.  In a digitized world, technological solutions to bridge the gap in […]

1 2 3 4 8